Literature DB >> 2378376

Diagnostic clinical findings of a new syndrome with night blindness, maculopathy, and enhanced S cone sensitivity.

M F Marmor1, S G Jacobson, M H Foerster, U Kellner, R G Weleber.   

Abstract

We studied eight patients who had night blindness, maculopathy (often cystoid), degenerative changes in the region of the vascular arcades, relatively mild visual field loss, and an unusual but characteristic electroretinogram. The dark-adapted electroretinogram showed no response to low-intensity stimuli that normally activate the rods, but large, slow responses to high-intensity stimuli. These large, slow waveforms persisted without change under light adaptation, and showed a striking mismatch to photopically balanced short and long wavelength stimuli (with sensitivity much greater to short than long wave-lengths). Since there is evidence from other studies that the electroretinogram and psychophysical responses represent hypersensitivity of short wavelength-sensitive (S or blue) cones, we propose that this disorder be called the enhanced S cone syndrome. There can be different degrees of severity in this syndrome, and progression appears to be slow.

Entities:  

Mesh:

Year:  1990        PMID: 2378376     DOI: 10.1016/s0002-9394(14)76980-6

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  45 in total

1.  Isolated foveal retinoschisis as a cause of visual loss in young females.

Authors:  S A Kabanarou; G E Holder; A C Bird; A R Webster; P E Stanga; S Vickers; B A Harney
Journal:  Br J Ophthalmol       Date:  2003-06       Impact factor: 4.638

2.  Detection of cystoid macular edema with three-dimensional optical coherence tomography versus fluorescein angiography.

Authors:  Yanling Ouyang; Pearse A Keane; Srinivas R Sadda; Alexander C Walsh
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-03-31       Impact factor: 4.799

3.  A novel mutation (Cys83Tyr) in the second zinc finger of NR2E3 in enhanced S-cone syndrome.

Authors:  Amândio Rocha-Sousa; Takaaki Hayashi; Nuno Lourenço Gomes; Susana Penas; Elisete Brandão; Paulo Rocha; Mitsuyoshi Urashima; Hisashi Yamada; Hiroshi Tsuneoka; Fernando Falcão-Reis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-08-20       Impact factor: 3.117

4.  A detailed phenotypic study of "cone dystrophy with supernormal rod ERG".

Authors:  M Michaelides; G E Holder; A R Webster; D M Hunt; A C Bird; F W Fitzke; J D Mollon; A T Moore
Journal:  Br J Ophthalmol       Date:  2005-03       Impact factor: 4.638

5.  Electroretinography and optical coherence tomography reveal abnormal post-photoreceptoral activity and altered retinal lamination in patients with enhanced S-cone syndrome.

Authors:  M Sustar; D Perovšek; I Cima; B Stirn-Kranjc; M Hawlina; J Brecelj
Journal:  Doc Ophthalmol       Date:  2015-02-07       Impact factor: 2.379

6.  Recessive NRL mutations in patients with clumped pigmentary retinal degeneration and relative preservation of blue cone function.

Authors:  Koji M Nishiguchi; James S Friedman; Michael A Sandberg; Anand Swaroop; Eliot L Berson; Thaddeus P Dryja
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-09       Impact factor: 11.205

7.  Progressive cone dystrophy with deutan genotype and phenotype.

Authors:  Hendrik P N Scholl; Jan Kremers; Dorothea Besch; Eberhart Zrenner; Herbert Jägle
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-08-05       Impact factor: 3.117

8.  Two-color pupillometry in enhanced S-cone syndrome caused by NR2E3 mutations.

Authors:  Frederick T Collison; Jason C Park; Gerald A Fishman; Edwin M Stone; J Jason McAnany
Journal:  Doc Ophthalmol       Date:  2016-03-31       Impact factor: 2.379

9.  New truncation mutation of the NR2E3 gene in a Japanese patient with enhanced S-cone syndrome.

Authors:  Kazuki Kuniyoshi; Takaaki Hayashi; Hiroyuki Sakuramoto; Hiroshi Mishima; Hiroshi Tsuneoka; Kazushige Tsunoda; Takeshi Iwata; Yoshikazu Shimomura
Journal:  Jpn J Ophthalmol       Date:  2016-08-13       Impact factor: 2.447

10.  Mapping of genetic modifiers of Nr2e3 rd7/rd7 that suppress retinal degeneration and restore blue cone cells to normal quantity.

Authors:  Neena B Haider; Weidong Zhang; Ron Hurd; Akihiro Ikeda; Arne M Nystuen; Jürgen K Naggert; Patsy M Nishina
Journal:  Mamm Genome       Date:  2008-02-20       Impact factor: 2.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.